Provided by Tiger Trade Technology Pte. Ltd.

Doximity, Inc.

28.34
+1.826.86%
Post-market: 28.350.0100+0.04%19:54 EDT
Volume:4.96M
Turnover:139.83M
Market Cap:5.05B
PE:33.64
High:28.63
Open:26.71
Low:26.68
Close:26.52
52wk High:74.33
52wk Low:17.15
Shares:178.25M
Float Shares:124.00M
Volume Ratio:1.87
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8426
EPS(LYR):0.9800
ROE:17.21%
ROA:10.95%
PB:5.51
PE(LYR):28.92

Loading ...

Doximity management to meet virtually with Piper Sandler

TIPRANKS
·
Jun 11

Dr. Martens Admits New Shares Linked to Employee Schemes on LSE

TIPRANKS
·
Jun 05

Dr. Martens Publishes 2026 Annual Report and Sets Date for AGM

TIPRANKS
·
Jun 02

Dr. Martens Links Executive Pay to Long-Term Performance With New Share Awards

TIPRANKS
·
Jun 02

Dr. Martens Sets Official Voting Share Capital at 967.9 Million

TIPRANKS
·
Jun 02

Dr. Martens Announces Planned Board Transition as Senior Independent Director to Step Down

TIPRANKS
·
May 27

Doximity CEO Tangney presents at William Blair Growth Stock Conference

Reuters
·
May 22

AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity

TIPRANKS
·
May 21

Peel Hunt Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
May 20

RBC Capital Remains a Hold on Dr. Martens Plc (DOCS)

TIPRANKS
·
May 20

Berenberg Bank Sticks to Its Buy Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
May 19

Doximity (DOCS) Receives a Hold from Truist Financial

TIPRANKS
·
May 19

Dr. Martens pivots to consumer-first model as profits surge 61%

TIPRANKS
·
May 19

Dr. Martens Plans Share Purchases for Employee Benefit Trust

TIPRANKS
·
May 19

Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI Spend - What's Changed

Simply Wall St.
·
May 17

DOCS, WIX, CAKE, SBUX, VRT Trending With Analysts

TIPRANKS
·
May 16

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)

TIPRANKS
·
May 16

RBC Capital Remains a Buy on Doximity (DOCS)

TIPRANKS
·
May 16

Doximity Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
May 15

Barclays Downgrades Doximity to Equalweight From Overweight, Adjusts Price Target to $20 From $38

MT Newswires Live
·
May 15